Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923350 · ClinicalTrials.gov registry record · NA
Avoiding Diabetes After Pregnancy Trial
A NA study of Weight Reduction, sponsored by Social & Scientific Systems.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT01923350: Completed NA study of Weight Reduction, sponsored by Social & Scientific Systems.
NCT01923350 is a NA study of Weight Reduction that has completed, run by Social & Scientific Systems. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01923350, a NA study of Weight Reduction, has completed, sponsored by Social & Scientific Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The Avoiding Diabetes After Pregnancy Trial (ADAPT) study was designed to test the effectiveness of interventions that potentially increase the adoption of Diabetes Prevention Program (DPP) elements by women who had a pregnancy with gestational diabetes mellitus (GDM). The study was conducted as an integrated trial with two separate arms: one to facilitate weight reduction and the other to increase diabetes testing. There were two hypotheses: 1. Women in the testing intervention will be more likely to have received a diabetes test within the 6 months post-intervention than women in the control group. 2. Women in the weight reduction intervention will have lost more weight at the 6-month and 9-month follow-up than women in the control group. The primary study aim was to determine the efficacy of a system of interactive technology-based supports to prompt women with a history of gestational diabetes to take steps to prevent diabetes. The secondary aims were focused on women's engagement: * To evaluate the impact of the weight reduction intervention in terms of participant engagement with the interactive technology-based supports. * To evaluate changes in the women's perception of their personal diabetes risk following after exposure to information about diabetes risk following a pregnancy with GDM. * To identify the determinants and motivators of and barriers to diabetes testing in the 6- to 12-week postpartum period and thereafter, using the Health Belief model to guide the study. There was an additional secondary aim involving metformin: * To evaluate the impact of the diabetes risk reduction intervention in terms of women seeking out their physician's advice on metformin treatment and receiving a metformin prescription, if appropriate.
Primary Outcome
Participants reported their weights online at baseline, 3 months, 6 months, and 9 months, and the difference in weight from baseline to 6 months was the primary measure of the intervention's success.
Conditions Studied
Interventions
- BEHAVIORAL Weight Reduction Intervention
- BEHAVIORAL Weight Reduction Control Arm
- BEHAVIORAL Tested for diabetes
- BEHAVIORAL Not tested for diabetes
Study Locations (1)
Maryland
- Social & Scientific Systems Inc. - Silver Spring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01923350 record still lists
NCT01923350 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Weight Reduction appearing as the primary indexed condition, and to 4 interventions - of which Weight Reduction Intervention is the first listed.
NCT01923350 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01923350 about?
NCT01923350 is a clinical study titled "Avoiding Diabetes After Pregnancy Trial". The Avoiding Diabetes After Pregnancy Trial (ADAPT) study was designed to test the effectiveness of interventions that potentially increase the adoption of Diabetes Prevention Program (DPP) elements by women who had a pregnancy with gestational diabetes mellitus (GDM). The study was conducted as an...
What is the current status of trial NCT01923350?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2011-12. Estimated completion is 2013-03.
What conditions does trial NCT01923350 study?
This clinical trial studies the following conditions: Weight Reduction.
What interventions are being tested in trial NCT01923350?
The interventions under investigation include: Weight Reduction Intervention (BEHAVIORAL), Weight Reduction Control Arm (BEHAVIORAL), Tested for diabetes (BEHAVIORAL), Not tested for diabetes (BEHAVIORAL).
Who is sponsoring clinical trial NCT01923350?
This trial is sponsored by Social & Scientific Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01923350 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01923350's enrollment target sits among peer trials
140 713th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia